2-piperidin-4-yl-benzimidazoles with broad spectrum antibacterial activities.

Bioorg Med Chem Lett

Ibis Therapeutics, A Division of Isis Pharmaceuticals, Inc., 2292 Faraday Avenue, Carlsbad, CA 92008, USA.

Published: October 2003

A series of 2-piperidin-4-yl-benzimidazoles were synthesized and evaluated for antibacterial activities. Certain compounds inhibit bacterial growth with low micromolar minimal inhibitory concentration (MIC). These benzimidazoles are effective against both Gram-positive and Gram-negative bacteria of clinical importance, particularly enterococci, and represent a new class of potential antibacterial agents.

Download full-text PDF

Source
http://dx.doi.org/10.1016/s0960-894x(03)00661-9DOI Listing

Publication Analysis

Top Keywords

antibacterial activities
8
2-piperidin-4-yl-benzimidazoles broad
4
broad spectrum
4
spectrum antibacterial
4
activities series
4
series 2-piperidin-4-yl-benzimidazoles
4
2-piperidin-4-yl-benzimidazoles synthesized
4
synthesized evaluated
4
evaluated antibacterial
4
activities compounds
4

Similar Publications

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!